Correlation Between Tonix Pharmaceuticals and Effector Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tonix Pharmaceuticals and Effector Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tonix Pharmaceuticals and Effector Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tonix Pharmaceuticals Holding and Effector Therapeutics, you can compare the effects of market volatilities on Tonix Pharmaceuticals and Effector Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tonix Pharmaceuticals with a short position of Effector Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tonix Pharmaceuticals and Effector Therapeutics.
Diversification Opportunities for Tonix Pharmaceuticals and Effector Therapeutics
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Tonix and Effector is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Tonix Pharmaceuticals Holding and Effector Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Effector Therapeutics and Tonix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tonix Pharmaceuticals Holding are associated (or correlated) with Effector Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Effector Therapeutics has no effect on the direction of Tonix Pharmaceuticals i.e., Tonix Pharmaceuticals and Effector Therapeutics go up and down completely randomly.
Pair Corralation between Tonix Pharmaceuticals and Effector Therapeutics
Given the investment horizon of 90 days Tonix Pharmaceuticals Holding is expected to generate 0.75 times more return on investment than Effector Therapeutics. However, Tonix Pharmaceuticals Holding is 1.33 times less risky than Effector Therapeutics. It trades about -0.14 of its potential returns per unit of risk. Effector Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 1,610 in Tonix Pharmaceuticals Holding on September 1, 2024 and sell it today you would lose (1,591) from holding Tonix Pharmaceuticals Holding or give up 98.82% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 61.71% |
| Values | Daily Returns |
Tonix Pharmaceuticals Holding vs. Effector Therapeutics
Performance |
| Timeline |
| Tonix Pharmaceuticals |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Tonix Pharmaceuticals and Effector Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tonix Pharmaceuticals and Effector Therapeutics
The main advantage of trading using opposite Tonix Pharmaceuticals and Effector Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tonix Pharmaceuticals position performs unexpectedly, Effector Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Effector Therapeutics will offset losses from the drop in Effector Therapeutics' long position.| Tonix Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Tonix Pharmaceuticals vs. Palisade Bio | Tonix Pharmaceuticals vs. Ibio Inc | Tonix Pharmaceuticals vs. Jaguar Animal Health |
| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |